Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl [NA]

View source ↗

Summary

The ULURU Inc. burn-treatment trial evaluating Altrazeal versus a typical carboxymethyl product was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Altrazeal

Snippet

Sponsor: ULURU Inc. | Conditions: Burn | NA | Status: TERMINATED